Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H23N7O10 |
| Molecular Weight | 497.4161 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC=C(N1CCOC(=O)CN(CC(O)=O)CC(=O)OCCN2C(C)=NC=C2[N+]([O-])=O)[N+]([O-])=O
InChI
InChIKey=AWSWJRUMDBPELJ-UHFFFAOYSA-N
InChI=1S/C18H23N7O10/c1-12-19-7-14(24(30)31)22(12)3-5-34-17(28)10-21(9-16(26)27)11-18(29)35-6-4-23-13(2)20-8-15(23)25(32)33/h7-8H,3-6,9-11H2,1-2H3,(H,26,27)
| Molecular Formula | C18H23N7O10 |
| Molecular Weight | 497.4161 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Sodium glycididazole (CMNA), a nitroimidazole compound that has a radiation-enhancing effect. This drug was studied in the treatment of patients with various tumors, such as non-small-cell lung cancer, esophageal carcinoma. CMNA combined with chemoradiotherapy participated in phase II clinical trials in patients with locally recurrent squamous cell esophageal carcinoma. It was shown, that CMNA improved curative effects without increasing adverse reactions, and significantly increase survival rates of the patients. The precise mechanism of action CMNA is not clear but is known that it acts through downregulation of ATM signaling pathway.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: WP2516 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26586399 |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02721576
Sodium Glycididazole (CMNa) 800mg/m2.Three times a week (once every other one day),before radiation therapy, total 5-6 weeks.
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:37:33 GMT 2025
by
admin
on
Mon Mar 31 22:37:33 GMT 2025
|
| Record UNII |
B2PT4D6Q3B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9914615
Created by
admin on Mon Mar 31 22:37:33 GMT 2025 , Edited by admin on Mon Mar 31 22:37:33 GMT 2025
|
PRIMARY | |||
|
DTXSID20432743
Created by
admin on Mon Mar 31 22:37:33 GMT 2025 , Edited by admin on Mon Mar 31 22:37:33 GMT 2025
|
PRIMARY | |||
|
298688-51-4
Created by
admin on Mon Mar 31 22:37:33 GMT 2025 , Edited by admin on Mon Mar 31 22:37:33 GMT 2025
|
PRIMARY | |||
|
B2PT4D6Q3B
Created by
admin on Mon Mar 31 22:37:33 GMT 2025 , Edited by admin on Mon Mar 31 22:37:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |